Biontex Laboratories GmbH was launched in 1997 as an innovative biotech company in the field of genetic engineering. The company's operations focus is on development of products, allowing efficient introduction of genetic material (transfection) and proteins (proteofection) into eukaryotic cells and foregrounding easy handling, low toxicity and high efficiency.
The current focus of our research is the development of all-new strategies to overcome the innate immune system, which was identified as a barrier for successful transfection. Our ultimate aim is to provide made-to-measure transfection system for all cell types.
Headquarters of Biontex Laboratories GmbH in Munich in "Münchner Gewerbehof - Laim"